Cargando…
Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis
It is important to develop minimally invasive biomarker platforms to help in the identification and monitoring of patients with Alzheimer’s disease (AD). Assisting in the understanding of biochemical mechanisms as well as identifying potential novel biomarkers and therapeutic targets would be an add...
Autores principales: | Hanas, Jay S., Hocker, James R. S., Vannarath, Christian A., Lerner, Megan R., Blair, Scott G., Lightfoot, Stan A., Hanas, Rushie J., Couch, James R., Hershey, Linda A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145311/ https://www.ncbi.nlm.nih.gov/pubmed/33946285 http://dx.doi.org/10.3390/brainsci11050583 |
Ejemplares similares
-
Distinguishing and Biochemical Phenotype Analysis of Epilepsy Patients Using a Novel Serum Profiling Platform
por: Hanas, Jay S., et al.
Publicado: (2020) -
Distinguishing and phenotype monitoring of traumatic brain injury and post-concussion syndrome including chronic migraine in serum of Iraq and Afghanistan war veterans
por: Hanas, Jay S., et al.
Publicado: (2019) -
Distinguishing patients with idiopathic epilepsy from solitary cysticercus granuloma epilepsy and biochemical phenotype assessment using a serum biomolecule profiling platform
por: Hanas, Jay S., et al.
Publicado: (2020) -
Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery
por: Hocker, James R., et al.
Publicado: (2020) -
The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension
por: Newnham, Michael, et al.
Publicado: (2019)